Issue 6/2019
Content (6 Articles)
Autoantibodies against P29ING4 are associated with complex regional pain syndrome
N. T. Baerlecken, R. Gaulke, N. Pursche, T. Witte, M Karst, M. Bernateck
Breast Cancer
Original Article
Retained or altered expression of major histocompatibility complex class I in patient-derived xenograft models in breast cancer
In Hye Song, Young-Ae Kim, Hyeonjin Lee, Hye Seon Park, In Ah Park, Chan Kyu Sim, Myeong Sup Lee, Gyungyub Gong, Hee Jin Lee
Antiphospholipid Syndrome
Original Article
A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome
Sebastián Udry, José Omar Latino, Cristina Belizna, Silvia Perés Wingeyer, Diego Santiago Fernández Romero, Gabriela de Larrañaga
Original Article
CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE
Ning Wang, Shuang Liang, Jingyi Jin, Liang Fang, Qianli Ma, Xian Wang, Yun Song, Lihua Chen
Breast Cancer
Original Article
Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I–deficient breast cancer cells
Ming-Zhen Zhao, Yu Sun, Xiao-Feng Jiang, Li Liu, Li Liu, Li-Xin Sun
Ovarian Cancer
Original Article
Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers
Bahareh Kashani, Zahra Zandi, Mohammad Reza Karimzadeh, Davood Bashash, Ali Nasrollahzadeh, Seyed H. Ghaffari